Biotin Anti-Human CD8a Antibody[OKT-8]

Biotin Anti-Human CD8a Antibody[OKT-8]

The Biotin Anti-Human CD8a Antibody[OKT-8] is a highly specific and reliable tool designed for the detection and analysis of CD8a antigen expression in human samples. This antibody is conjugated with biotin, allowing for easy and efficient detection using streptavidin-based detection systems. With its exceptional sensitivity and specificity, this antibody is an essential component for various research applications, including flow cytometry, immunohistochemistry, and immunofluorescence.

This antibody is derived from the OKT-8 hybridoma, ensuring consistent and reproducible results. It recognizes the CD8a antigen, a cell surface glycoprotein expressed on cytotoxic T cells, natural killer cells, and a subset of dendritic cells. By targeting CD8a, this antibody enables the identification and characterization of these immune cell populations, facilitating a deeper understanding of immune responses and their role in various diseases, such as cancer, autoimmune disorders, and infectious diseases.

The Biotin Anti-Human CD8a Antibody[OKT-8] offers exceptional performance in terms of sensitivity, specificity, and signal-to-noise ratio. Its high affinity for CD8a ensures accurate and reliable detection, even in low-abundance cell populations. This antibody is optimized for use in multi-color flow cytometry experiments, allowing for simultaneous analysis of multiple markers. Additionally, it can be used in combination with other fluorochrome-conjugated antibodies to provide a comprehensive immune cell profiling. With its superior quality and versatility, this antibody is an invaluable tool for researchers in immunology, oncology, and infectious diseases, enabling groundbreaking discoveries and advancements in the field.